PIKFYVE and B-cell non-Hodgkin lymphoma: Recently, Apilimod has been shown to possess anticancer activity against B-cell non-Hodgkin lymphoma 52 and is currently tested in a clinical trial, and different inhibitors of PIKfyve are promising anticancer drugs 53.